Catalyst Wire Dossier Catalyst Wire Dossier

hUC-MSCs Intravenous Infusion Therapy

human umbilical cord-derived mesenchymal stem cells · Southeast University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hUC-MSCs Intravenous Infusion Therapy, covering 2024-07-17 to 2024-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS [Phase 1, Phase 2]

See pricing